About HALO(TM) Breast Pap Test
Drawing on the proven success of screening for the cellular and biological changes that signal an increased risk of developing prostate and cervical cancer, the HALO Breast Pap system collects Nipple Aspirate Fluid (NAF) using gentle suction like a breast pump. The screening occurs in the primary care setting, such as the ob-gyn, family practice, or internist office, where most women present for well-woman healthcare. A large body of clinical research demonstrates that the cytological assessment of Nipple Aspirate Fluid, or NAF, can identify a woman's relative risk of developing breast cancer. The presence in NAF of a known biomarker, Atypical Ductal Hyperplasia (ADH), confers a 400-500 percent greater risk of developing breast cancer than women who do not produce fluid.
About NeoMatrix, LLC
Based in Irvine, Calif., NeoMatrix(C) develops innovative devices that
allow women and their Ob-Gyns to promote optimal breast health. The
company's premier product, the HALO Breast Pap Test System, is the first
fully automated, noninvasive breast disease screening device designed for
use in the Ob-Gyn office. The System has been FDA cleared for the
collection of nipple aspirate fluid for cytological evaluation for the
|SOURCE NeoMatrix, LLC|
Copyright©2007 PR Newswire.
All rights reserved